Bristol Myers Squibb vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026?
Key PointsBristol Myers Squibb offers a significant yield and recovery in net income, supported by its strong oncology and cardiovascular segments.
Key PointsBristol Myers Squibb offers a significant yield and recovery in net income, supported by its strong oncology and cardiovascular segments.